IndiaInfoline » Markets » MARKSANS

Marksans Pharma Ltd - Share Price

MARKSANS

Open

13.90

Prev. Close

13.85

Turnover (lac.)

82

Day's High

14.45

Day's Low

13.90

52 Week's High

29.65

52 Week's Low

11.40

Book Value

12

Face Value

1

Mkt Cap (Cr.)

583

P/E

16.71

EPS

0.85

Divi. Yield

0.35

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd439.2540.24105,246.83823.160.633,215.0198.33
Divis Laboratories Ltd1,842.0037.8948,844.89352.830.871,403.92266.77
Dr Reddys Laboratories Ltd2,821.5018.6546,904.851,365.100.713,435.30852.70
Cipla Ltd461.2515.7637,195.20737.380.653,230.08209.72
Biocon Ltd292.35117.9635,106.00106.100.17523.9059.29

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

No Company Summary found

Registered Office

11th Flr GRANDEUR Oshiwara,Veera Desai Extn Rd Andheri(W),Mumbai, Maharashtra,400053

Tell. : +91-22-40012000
Website : http://www.marksanspharma.com
Email : companysecretary@marksanspharma.com

Registrar Office

1st Flr Bharat Tin W, Andheri (East), Mumbai - 400059 INDIA

Tell. : +91-22-62638200
Website : www.bigshareonline.com
Email : investor@bigshareonline.com

Latest Release by marksans-pharma-ltd

View

- <

Reco. Price

Jun 06,2019 04:05 PM

Target Price

Target Returns:

0.00%

Result Express

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    12 Nov 2019

    Annc. Date

    01 Nov 2019

    Quarterly ResultsIn terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requiremen... More

  • Purpose

    AGM

    Exp. Date

    26 Sep 2019

    Annc. Date

    28 Aug 2019

    AGM 26/09/2019This is to inform you that the 27th Annual General Meeting (AGM) of Marksans Pharma Li... More

  • Purpose

    Dividend

    Annc. Date

    29 May 2019

    Effective. Date

    19 Sep 2019

    Divi. Type

    Final

    Divi.(%)

    5

    Divi. Amt.

    0.05

    Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held ... More